Global Nitric Oxide Market Professional Survey Report 2019
Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
The global Nitric Oxide market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Nitric Oxide volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nitric Oxide market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nitric Oxide in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nitric Oxide manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Mallinckrodt
Praxair
Air Liquide
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
99.92% Purity
99.99% Purity
Other
Segment by Application
ARDS
PPHN
Other Diseases
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
The global Nitric Oxide market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Nitric Oxide volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nitric Oxide market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nitric Oxide in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nitric Oxide manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Mallinckrodt
Praxair
Air Liquide
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
99.92% Purity
99.99% Purity
Other
Segment by Application
ARDS
PPHN
Other Diseases
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
